1. Home
  2. TSLX vs OCUL Comparison

TSLX vs OCUL Comparison

Compare TSLX & OCUL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Sixth Street Specialty Lending Inc.

TSLX

Sixth Street Specialty Lending Inc.

HOLD

Current Price

$18.54

Market Cap

1.8B

Sector

Finance

ML Signal

HOLD

Logo Ocular Therapeutix Inc.

OCUL

Ocular Therapeutix Inc.

HOLD

Current Price

$8.44

Market Cap

1.9B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
TSLX
OCUL
Founded
2010
2006
Country
United States
United States
Employees
N/A
N/A
Industry
Investment Managers
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.8B
1.9B
IPO Year
2011
2014

Fundamental Metrics

Financial Performance
Metric
TSLX
OCUL
Price
$18.54
$8.44
Analyst Decision
Buy
Strong Buy
Analyst Count
9
11
Target Price
$21.72
$22.90
AVG Volume (30 Days)
1.5M
7.6M
Earning Date
05-14-2026
05-06-2026
Dividend Yield
11.24%
N/A
EPS Growth
N/A
N/A
EPS
1.81
N/A
Revenue
N/A
$1,990,000.00
Revenue This Year
N/A
$9.35
Revenue Next Year
$1.92
$92.88
P/E Ratio
$10.08
N/A
Revenue Growth
N/A
3.48
52 Week Low
$16.99
$6.23
52 Week High
$25.17
$16.44

Technical Indicators

Market Signals
Indicator
TSLX
OCUL
Relative Strength Index (RSI) 46.00 40.76
Support Level $16.99 $8.36
Resistance Level $22.46 $12.20
Average True Range (ATR) 0.57 0.67
MACD 0.12 -0.11
Stochastic Oscillator 83.52 2.11

Price Performance

Historical Comparison
TSLX
OCUL

About TSLX Sixth Street Specialty Lending Inc.

Sixth Street Specialty Lending Inc is a specialty finance company focused on providing flexible, fully committed financing solutions to middle market companies located in the United States of America. It partners with companies across a variety of industries and excel at providing creative solutions to companies with complex business models that may have limited access to capital. The company seeks to generate current income in U.S.-domiciled middle-market companies through direct originations of senior secured loans and, to a lesser extent, originations of mezzanine and unsecured loans and investments in corporate bonds and equity securities.

About OCUL Ocular Therapeutix Inc.

Ocular Therapeutix Inc is a biotechnology company that specializes in therapies for diseases and conditions of the eye. The company uses its proprietary hydrogel platform technology to deliver therapeutic agents to the eye. Its pipeline consists of eye medication that aims to overcome the limitations of current eye-drop-based therapies for ophthalmic diseases and conditions. Its pipeline product includes Dextenza, OTX-TIC, OTX-TKI, and OTX-IVT.

Share on Social Networks: